Rising Biosciences (Rising Biosciences) Inventory-to-Revenue : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Rising Biosciences's Average Total Inventories for the quarter that ended in . 20 was $0.00 Mil. Rising Biosciences's Revenue for the three months ended in . 20 was $0.00 Mil.

Rising Biosciences's Inventory-to-Revenue for the quarter that ended in . 20 stayed the same from . 20 (0.00) to . 20 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Rising Biosciences Inventory-to-Revenue Historical Data

The historical data trend for Rising Biosciences's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Inventory-to-Revenue Chart

Rising Biosciences Annual Data

Trend

Inventory-to-Revenue

Rising Biosciences Quarterly Data

Inventory-to-Revenue

Competitive Comparison of Rising Biosciences's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Inventory-to-Revenue falls into.

Rising Biosciences Inventory-to-Revenue Calculation

Rising Biosciences's Inventory-to-Revenue for the fiscal year that ended in . 20 is calculated as

	Inventory-to-Revenue (A: . 20 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: . 20 )	+	Total Inventories (A: . 20 ))	/	count )	/	Revenue (A: . 20 )
=	( (	+	)	/	1 )	/
=	0					/
=	N/A

Rising Biosciences's Inventory-to-Revenue for the quarter that ended in . 20 is calculated as

	Inventory-to-Revenue (Q: . 20 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: . 20 )	+	Total Inventories (Q: . 20 ))	/	count )	/	Revenue (Q: . 20 )
=	( (	+	)	/	1 )	/
=	0					/
=

Rising Biosciences (GREY:RBII) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Rising Biosciences's Days Inventory for the three months ended in . 20 is calculated as:

Days Inventory	=	Average Total Inventories (Q: . 20 )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
	=	0	/		*	365 / 4
	=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Rising Biosciences's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: . 20 )	/	Average Total Inventories (Q: . 20 )
	=		/	0
	=

Rising Biosciences Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Inventory-to-Revenue

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.